Navigation Links
Medicare Part B Subscribers Who Made a Percentage Co-Payment for Certain Drugs May Be Able To Get a Refund from a Class Action Settlement
Date:4/4/2011

BOSTON, April 4, 2011 /PRNewswire-USNewswire/ -- There has been a proposed Settlement in a class action lawsuit involving several drug manufacturers and approximately 200 drugs used to treat a variety of medical conditions including: cancer, HIV, asthma, allergies, infections, pain & inflammation, gastrointestinal, lung & blood issues, and many other conditions.  These drugs are often injected in a doctor's office or clinic.

This lawsuit is not about whether these drugs are safe or effective. This lawsuit claims that consumers paid too much for the drugs.

The drug manufacturers have agreed to settle the lawsuit and pay $125 million.  Approximately $21.8 million will be available to pay consumer claims including Medicare Part B subscribers.

Medicare Part B subscribers are eligible for a refund if they made percentage co-payments not covered by insurance for any of the drugs included in this Settlement between January 1, 1991 and January 1, 2005.  A percentage co-payment varies with the cost of the drug. A flat co-payment never varies; it's always the same no matter how much the drug costs.  Consumers with supplemental insurance who did not make a co-payment or paid only a flat co-payment are not eligible for a refund.  

In order to receive a payment, consumers must file claims by July 1, 2011.  Consumers who do not wish to remain in the Settlement must request to be excluded in writing postmarked by May 24, 2011. Consumers who exclude themselves retain the right to sue the Defendants on their own.  Consumers may object to or comment on the Settlement in writing postmarked by May 24, 2011.

Class Counsel Edward Notargiacomo says "this settlement is a victory for the millions of Medicare Part B Subscribers who overpaid for prescription medications."

For more information about the Settlement, a complete list of covered drugs, or information on how to file a claim: visit www.AWPtrack2Settlement.com or call 1-877-465-8136.  


'/>"/>
SOURCE Hagens Berman Sobol Shapiro LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
2. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
3. Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions
4. Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities
5. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
6. Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home
7. Medicare Announces Expanded Coverage for Anticoagulation Patients, Opening the Door for More Patients to Test PT/INR at Home
8. QMed, Inc. Receives 2-Year Extension of Medicare Coordinated Care Demonstration Project by CMS
9. Observational Study Finds Changes in Medicare Reimbursement for Erythropoiesis-Stimulating Agents Associated With Increased Need for Blood Transfusion
10. Study Shows Brain Fitness can Save Medicare Billions
11. Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... 6, 2017  Robert G. Szewc, M.D., is recognized ... in recognition of his contributions to the Medical field.  ... Nephrologist at the practice of Kidney and Hypertension Specialists, ... and hypertension solutions. He has worked in this position ... experience, as well as expertise in kidneys, hypertension, chronic ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are used to treat ... if one isn’t accessible in certain locations, the risk of death can be ... with this idea," said an inventor from Ridgecrest, Calif. , The MOBILE AUTOMATED ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from ... in Educational Leadership and Administration at St. Thomas University in Miami, Florida, was ...
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... and more products at customers’ doorstep. According to Smart Mart, customers can now ... stated to offer wearable, and customers can find clothing at discounted prices. Apart ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for Medical ... p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing ... The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning ...
Breaking Medicine News(10 mins):